Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
18 déc. 2018 09h25 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies...